Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials.
about
Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.Current trends in the management of gastroesophageal reflux disease: a review.Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment.Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD?Scintigraphic scoring system for grading severity of gastro-esophageal reflux on 99mTc sulfur colloid gastro-esophageal reflux scintigraphy: A prospective study of 39 cases with pre and post treatment assessment.
P2860
Prokinetic drug utility in the treatment of gastroesophageal reflux esophagitis: a systematic review of randomized controlled trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prokinetic drug utility in the ...... randomized controlled trials.
@en
Prokinetic drug utility in the ...... randomized controlled trials.
@nl
type
label
Prokinetic drug utility in the ...... randomized controlled trials.
@en
Prokinetic drug utility in the ...... randomized controlled trials.
@nl
prefLabel
Prokinetic drug utility in the ...... randomized controlled trials.
@en
Prokinetic drug utility in the ...... randomized controlled trials.
@nl
P2093
P2860
P1433
P1476
Prokinetic drug utility in the ...... randomized controlled trials.
@en
P2093
Fernando A Serrano
Gisela Di Stilio
Hugo N Catalano
María F Koch
Matías E Manzotti
P2860
P304
P577
2007-12-04T00:00:00Z